Plasbumin - 13533-690-27 - (Albumin (Human))

Alphabetical Index


Drug Information of Plasbumin

Product NDC: 13533-690
Proprietary Name: Plasbumin
Non Proprietary Name: Albumin (Human)
Active Ingredient(s): 2.5    g/50mL & nbsp;   Albumin (Human)
Administration Route(s): INTRAVENOUS
Dosage Form(s): SOLUTION
Coding System: National Drug Codes(NDC)

Labeler Information of Plasbumin

Product NDC: 13533-690
Labeler Name: Grifols Therapeutics Inc.
Product Type: PLASMA DERIVATIVE
FDA Application Number: BLA101138
Marketing Category: BLA
Start Marketing Date: 19940926

Package Information of Plasbumin

Package NDC: 13533-690-27
Package Description: 1 VIAL in 1 CARTON (13533-690-27) > 500 mL in 1 VIAL (13533-690-28)

NDC Information of Plasbumin

NDC Code 13533-690-27
Proprietary Name Plasbumin
Package Description 1 VIAL in 1 CARTON (13533-690-27) > 500 mL in 1 VIAL (13533-690-28)
Product NDC 13533-690
Product Type Name PLASMA DERIVATIVE
Non Proprietary Name Albumin (Human)
Dosage Form Name SOLUTION
Route Name INTRAVENOUS
Start Marketing Date 19940926
Marketing Category Name BLA
Labeler Name Grifols Therapeutics Inc.
Substance Name ALBUMIN (HUMAN)
Strength Number 2.5
Strength Unit g/50mL
Pharmaceutical Classes Human Serum Albumin [EPC],Increased Intravascular Volume [PE],Increased Oncotic Pressure [PE],Osmotic Activity [MoA],Serum Albumin [Chemical/Ingredient]

Complete Information of Plasbumin


General Information